Skip to main content
Emcure Pharmaceuticals Limited logo

Emcure Pharmaceuticals Limited — Investor Relations & Filings

Ticker · EMCURE ISIN · INE168P01015 LEI · 335800WYB6OIBY9EOZ42 BSE.NS Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2026-02-17 Regulatory Filings
Country IN India
Listing BSE.NS EMCURE

About Emcure Pharmaceuticals Limited

https://www.emcure.com

Emcure Pharmaceuticals Limited is a research-driven global pharmaceutical organization engaged in the development, manufacturing, and marketing of a broad range of differentiated pharmaceutical products. The company maintains a diverse portfolio across several key therapeutic areas, including gynaecology, cardiovascular, oncology, anti-infectives, and HIV/AIDS. With a strong emphasis on research and development, Emcure operates multiple state-of-the-art manufacturing facilities and R&D centers globally. Its business model focuses on complex generics and innovative formulations, serving healthcare needs in over 70 countries. The company is recognized for its vertically integrated operations and commitment to high-quality standards, catering to both regulated and emerging markets worldwide.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of the schedule of upcoming analyst/investor meetings. It references compliance with SEBI regulations about disclosure requirements. The content is about the schedule of investor conferences and meetings, explicitly stating no unpublished price sensitive information will be shared. There are no financial statements, no detailed financial data, no report attachments, or voting results. The document is short (1925 characters) and is an announcement of a meeting schedule rather than a report or detailed presentation. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other more specific categories like Investor Presentation or Earnings Release, which would contain substantive financial or strategic content.
2026-02-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the schedule of upcoming analyst and investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements, indicating it is an official regulatory communication. The content is about informing the exchanges of planned investor interactions, with no financial data, report content, or voting results included. The document length is short (1914 characters), and it does not contain any financial statements or detailed report information. Therefore, it is not an Annual Report, Earnings Release, or any detailed financial report. It is also not a report publication announcement since it does not mention any report release. The document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings without fitting into other specific categories.
2026-02-17 English
Shareholders meeting
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding a Notice of Postal Ballot for the re-appointment of independent directors of Emcure Pharmaceuticals Limited. It references compliance with SEBI Listing Regulations and the Companies Act, 2013, and details the voting process and timelines for shareholders to approve the resolutions electronically. The content is focused on informing about the postal ballot notice and the voting procedure rather than presenting financial data or results. It is not an annual report, earnings release, or management discussion, but rather a regulatory announcement about a shareholder voting process. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or closely related. However, since this is the notice of the postal ballot and not the results, it is best classified under Regulatory Filings (RNS) as a general regulatory announcement about the voting process and notice, not the actual voting results or AGM materials. The document length is substantial and contains detailed regulatory references, supporting this classification.
2026-02-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 98% confidence The document is the full transcript of Emcure Pharmaceuticals’ Q3 FY26 earnings conference call, including management presentations, financial results discussion, and Q&A preamble. It is not just an announcement or summary, but the complete call transcript, fitting the definition of a Call Transcript (CT).
2026-02-10 English
Updates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It informs about an incident of fire at the company's manufacturing plant, providing details about the event, expected impact, insurance coverage, and operational disruption. The document is relatively short (3505 characters) and serves as an immediate disclosure of a material event rather than a detailed financial report or analysis. It does not contain financial statements, management discussion, or audit information. This type of filing is a regulatory announcement about a material event affecting the company, fitting the category of Regulatory Filings (RNS).
2026-02-07 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the newspaper publication of unaudited financial results for the quarter and nine months ended December 31, 2025. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of financial results. The document contains extracts of the unaudited financial results published in newspapers and uploaded on the company's website. The document length is 1946 characters, which is relatively short and primarily serves as an announcement of the publication of financial results rather than the full financial report itself. Therefore, according to the 'Menu vs Meal' rule, this document is an announcement of the report publication, not the report itself. Hence, the appropriate classification is Report Publication Announcement (RPA).
2026-02-05 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.